Researcher Profiles

Return to member profile

Ping Xie, PhD

Selected Publications

  1. Lalani, A. I., Moore, C. R., Luo, C., Kreider, B. Z., Liu, Y., Morse, H. C., and Xie, P. Myeloid Cell TRAF3 Regulates Immune Responses and Inhibits Inflammation and Tumor Development in Mice. J Immunol, in press.
  2. Xie, P., Moore, C. R., Swerdel, M. R., and Hart, R. P. (2014). Transcriptomic profiling of splenic B lymphomas spontaneously developed in B cell-specific TRAF3-deficient mice. Genomics data, 2, 386-388.
  3. Edwards, S., Baron, J., Moore, C. R., Liu, Y., Perlman, D. H., Hart, R. P., and Xie, P. (2014). Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes. J Hematol Oncol, 7, 56.
  4. Edwards, S. K., Desai, A., Liu, Y., Moore, C. R., and Xie, P. (2014). Expression and function of a novel isoform of Sox5 in malignant B cells. Leukemia Res, 38, 393-401.
  5. Edwards, S. K., Moore, C. R., Liu, Y., Grewal, S., Covey, L. R., and Xie, P. (2013). N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. BMC cancer, 13, 481.
  6. Xie, P. (2013). TRAF molecules in cell signaling and in human diseases. J Mol Signal, 8, 7.
  7. Perkins, D. J., Polumuri, S. K., Pennini, M. E., Lai, W., Xie, P., and Vogel, S. N. (2013). Reprogramming of murine Macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathogens, 9, e1003479.
  8. Moore, C.R., Y. Liu, C. Shao, L.R. Covey, H.C. Morse, and P. Xie (2012) Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice., Leukemia 26: 1122-7.
  9. Xie, P., J. Poovassery, L.L. Stunz, S.M. Smith, M.L. Schultz, L.E. Carlin, and G.A. Bishop (2011) Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes., J Leukoc Biol 90: 1149-57.
  10. Xie, P., Kraus, Z.J., Stunz, L.L., Liu, Y., and Bishop, G.A. (2011) TNF Receptor-associated Factor 3 is required for T Cell-mediated immunity and TCR/CD28 signaling. J Immunol 186: 143-55.
  11. Xie, P., Kraus, Z.J., Stunz, L.L., and Bishop, G.A. (2008) Roles of TRAF molecules in B lymphocyte function. Cytokine Growth Factor Rev 19:199-207.
  12. Xie, P., Stunz, L.L., Larison, K.D., Yang, B., and Bishop, G.A. (2007) Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27:253-67.
  13. Bishop, G.A. and Xie, P. (2007) Multiple roles of TRAF3 signaling in lymphocyte function., Immunol Res 39:22-32.
  14. Xie, P., Hostager, B.S., Munroe, M.E., Moore, C.R., and Bishop, G.A. (2006) Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J Immunol 176:5388-400.
  15. Xie, P., Hostager, B.S., and Bishop, G.A. (2004) Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J Exp Med 199:661-71.